Egoropal

Medicinal product

(Invented) name

Egoropal

Active substance (s)

Paliperidonas

Strength

25 mg

Pharmaceutical form

pailginto atpalaidavimo injekcinė suspensija užpildytame švirkšte

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05AX13, Paliperidone

Marketing authorisation holder

Egis Pharmaceuticals PLC, Vengrija

Date of authorisation

2022-01-17

Date of renewal

Documents

4871_4875 Egoropal PCS PL 2023 12 16.docx

4871_4875 Pakuotės lapelis 2023 12 16.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

DK/H/3176/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Užpildytame švirkšte yra:	1 vnt.
Paliperidonas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107851	93956	1093956	užpildytas švirkštas	ir 2 adatos N1		Receptinis	LT/1/22/4871/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-10-30	Išregistruotas
2022-01-17	Registruotas